Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-1273) for males age 18-64 years

Yogurtcu, ON; Funk, PR; Forshee, RA; Anderson, SA; Marks, PW; Yang, H

Yang, H (通讯作者),US FDA, Off Biostat & Pharmacovigilance, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,WO71, Silver Spring, MD 20993 USA.

VACCINE: X, 2023; 14 ():

Abstract

Since the authorization of the Moderna mRNA COVID-19 vaccine, real-world evidence has indicated its effectiveness in preventing COVID-19 cases. Howeve......

Full Text Link